| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $53.8M | +4.8% | +33.7% |
| Cost of Revenue | $16.1M | +0.4% | +10.9% |
| Gross Profit | $37.7M | +6.9% | +46.6% |
| R&D Expense | $4.6M | -12.5% | -5.1% |
| SG&A Expense | $37.2M | -15.9% | +9.1% |
| Operating Income | -$4.0M | +71.5% | +69.4% |
| Pre-tax Income | -$10.7M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $70.6M | +29.3% | — |
| Accounts Receivable | $71.4M | +1.9% | +6.2% |
| Inventory | $88.2M | -6.9% | +31.3% |
| Current Assets | $239.6M | +4.6% | +31.0% |
| Total Assets | $338.9M | +2.8% | +19.9% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$50.7M | — | — |
| Capital Expenditures | $4.2M | — | — |
| Investing Cash Flow | -$5.4M | — | — |
| Financing Cash Flow | $34.4M | — | — |
| Free Cash Flow | -$55.0M | — | — |
| +31.2% |
| +33.7% |
| Income Tax | $424K | -57.8% | -16.9% |
| Net Income | -$11.1M | +32.8% | +33.2% |
| EPS (Basic) | -$0.38 | +33.3% | +35.6% |
| EPS (Diluted) | -$0.38 | +33.3% | +35.6% |
| $72.0M |
| -10.9% |
| +42.5% |
| Long-term Debt | $246.5M | +11.5% | +26.8% |
| Total Liabilities | $322.5M | +5.1% | +29.0% |
| Stockholders' Equity | $16.4M | -28.1% | -50.0% |